Literature DB >> 23396265

Source and clinical motivation of orders for contrast-enhanced sonography (CEUS) of the liver: A prospective single-center survey.

O Catalano1, F Sandomenico, A Nunziata, P Vallone, M Mattace Raso, S V Setola, A Gallipoli D'Errico.   

Abstract

Contrast-enhanced sonography (CEUS) has become a routine part of diagnostic imaging of the liver. Its possibilities, limitations, and indications have been defined in adequately large clinical series and in guidelines and recommendations. We prospectively evaluated physicians' orders for hepatic CEUS received in the radiology department of a large oncology center in Naples, Italy from May 2009 to April 2010. Radiologists performing the CEUS examinations filled out a form that included patient demography, source and type of patient referral, and clinical indications for the examination. During the study period, 564 patients aged 17-86 years (mean, 58 years) were referred to our department for CEUS liver studies (total: 644; 491 outpatient studies, 153 inpatient studies). This included 4 examinations that were ordered by the patient's physician but not performed by our staff. The majority of the CEUS examinations (n = 583; 90.5%) were regularly scheduled procedures ordered by clinical specialists from our center (77.3%) or other centers (11.8%); by general practitioners (on their own initiative) (0.8%); or by other figures (0.6%). The remaining 61 examinations (9.5%) were unscheduled procedures done on the initiative of a radiologist following conventional sonography (US). Fewer than half (47.8%) of the examinations were requested as first-line assessments. The others were ordered to clarify inconclusive findings generated by conventional US (30%) or by a more sophisticated imaging study (CT, MRI, PET) (16.1%) or to resolve discrepancies between CT, MRI, and/or PET findings (6%). CEUS is a relatively noninvasive, low-cost imaging study that is simple to perform and requires no particular patient preparation. This may explain its increasing use to clarify doubts raised by conventional US and other more sophisticated imaging studies.

Entities:  

Keywords:  Contrast-enhanced sonography; Focal liver lesions; Indications; Liver; Patient referral

Year:  2011        PMID: 23396265      PMCID: PMC3558109          DOI: 10.1016/j.jus.2011.04.005

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  25 in total

Review 1.  Microbubble-enhanced US in body imaging: what role?

Authors:  Stephanie R Wilson; Peter N Burns
Journal:  Radiology       Date:  2010-10       Impact factor: 11.105

2.  [Contrast-enhanced ultrasound for the characterization of incidental liver lesions - an economical evaluation in comparison with multi-phase computed tomography].

Authors:  F L Giesel; S Delorme; R Sibbel; H-U Kauczor; M Krix
Journal:  Ultraschall Med       Date:  2009-06-02       Impact factor: 6.548

3.  [Usefulness of contrast-enhanced ultrasonography in daily clinical practice: a multicenter study in Spain].

Authors:  C Nicolau Molina; T Fontanilla Echeveste; J L Del Cura Rodríguez; F Cruz Villalón; T Ripollés González; B Baudet Naveros; M A J Velasco Marcos; C Garre Sánchez; R Huertas Arroyo; L Hernández García; S J Pitti Reyes; R A Gómez Rodríguez; M A J Calvo López; A Maroto Genover; G Alvarez Bustos; M Poch Zatarain; A Talegón Meléndez
Journal:  Radiologia       Date:  2009-12-30

4.  Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.

Authors:  T V Bartolotta; A Taibbi; M Midiri; L La Grutta; M De Maria; R Lagalla
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

5.  Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.

Authors:  F Laghi; O Catalano; M Maresca; F Sandomenico; A Siani
Journal:  Ultraschall Med       Date:  2010-06-01       Impact factor: 6.548

6.  Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

Authors:  Fabio Piscaglia; Simona Leoni; Giuseppe Cabibbo; Alberto Borghi; Grazia Imbriaco; Rita Golfieri; Luigi Bolondi
Journal:  Dig Liver Dis       Date:  2010-04-24       Impact factor: 4.088

7.  Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions.

Authors:  C Beaton; D Cochlin; N Kumar
Journal:  Eur J Surg Oncol       Date:  2009-08-25       Impact factor: 4.424

8.  Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI.

Authors:  Hervé Trillaud; Jean-Michel Bruel; Pierre-Jean Valette; Valérie Vilgrain; Gérard Schmutz; Raymond Oyen; Wieslaw Jakubowski; Jan Danes; Vlastimil Valek; Christian Greis
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

9.  Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).

Authors:  D Strobel; K Seitz; W Blank; A Schuler; C Dietrich; A von Herbay; M Friedrich-Rust; G Kunze; D Becker; U Will; W Kratzer; F W Albert; C Pachmann; K Dirks; H Strunk; C Greis; T Bernatik
Journal:  Ultraschall Med       Date:  2008-10       Impact factor: 6.548

Review 10.  Contrast-enhanced ultrasound in the detection and characterization of liver tumors.

Authors:  Hyun-Jung Jang; Hojun Yu; Tae Kyoung Kim
Journal:  Cancer Imaging       Date:  2009-11-06       Impact factor: 3.909

View more
  1 in total

1.  Contrast enhancement ultrasound application in focal liver lesions characterization: a retrospective study about guidelines application (SOCEUS-CEUS survey).

Authors:  Mirko D'Onofrio; Laura Romanini; Carla Serra; Fabrizio Magnolfi; Michele Bertolotto; Emilio Quaia; Gino Puntel; Alessandro Colleoni; Erica Fiorini; Cristina Cenci; Elena Santi; Valentina Ciaravino; Francesco Laffranchi; Orlando Catalano; Vito Cantisani; Fabrizio Calliada; Lorenzo Derchi
Journal:  J Ultrasound       Date:  2015-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.